Alnylam Pharmaceuticals
ALNY
#634
Rank
โ‚น2.689 T
Marketcap
โ‚น20,853
Share price
-0.80%
Change (1 day)
52.86%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company